NCT04083755View on ClinicalTrials.gov

Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)

PHASE4RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
AnemiaPeripheral Arterial Occlusive Disease
Interventions
DRUG

Ferric Carboxymaltose Injection [Injectafer]

1000mg intravenous

OTHER

no treatment or oral iron supplementation

No treatment or treatment oral with iron supplementation if iron-deficiency anemia

Trial Locations (5)

48903

RECRUITING

Servicio de Angiología y Cirugía vascular del Hospital Universitario Cruces, Barakaldo

48960

RECRUITING

Hospital de Galdakao-Usansolo., Galdakao

Unknown

NOT_YET_RECRUITING

Hospital de Getafe, Getafe

NOT_YET_RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

RECRUITING

Hospital Universitario La Paz, Madrid

All Listed Sponsors
collaborator

Sociedad Espanola de Angiologia y Cirugia Vascular

NETWORK

lead

Biocruces Bizkaia Health Research Institute

OTHER_GOV